New FDC - BE reference products [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2015-11-09 09:48 (3881 d 10:41 ago) – Posting: # 15627
Views: 3,946

Dear nobody
As I explained, it is a new fixed dose combination with known APIs, there is no reference product in the strict sense, only mono product references but if you do not aim for substitution indication (according to §10(b)) but go for a mixed application according to §8.3 do you need to demonstrate BE against the European mono products?
Looking forward to your reply.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
177 visitors (0 registered, 177 guests [including 31 identified bots]).
Forum time: 21:30 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5